Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin F Gibson

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Heart & Lung : the Journal of Critical Care|June 22, 2010
Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partnersKathleen Oare Lindell, Ellen Olshansky, Mi-Kyung Song, et al.
American Journal of Respiratory Cell and Molecular Biology|March 3, 2009
WNT5A is a regulator of fibroblast proliferation and resistance to apoptosisLouis J Vuga, Ahmi Ben-Yehudah, Elizabetha Kovkarova-Naumovski, et al.
Annals of the American Thoracic Society|May 18, 2021
Nurse-Led Palliative Care Clinical Trial Improves Knowledge and Preparedness in Caregivers of Patients with Idiopathic Pulmonary FibrosisKathleen Oare Lindell, Sara Jo Klein, Melinda S Veatch, et al.
Rheumatology (Oxford, England)|January 14, 2017
Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosisRohit Aggarwal, Christine McBurney, Frank Schneider, et al.
Annals of the American Thoracic Society|February 13, 2025
Reply to Archontakis Barakakis and Fortis: Oxygen Supplementation Goals Beyond Correcting Ambulatory Oxygen SaturationKristopher P Clark, Seyed Mehdi Nouraie, Kathleen O Lindell, et al.
Annals of the American Thoracic Society|November 20, 2024
A Ramped Treadmill Protocol Exercise Test Identifies Higher Ambulatory Oxygen Needs in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary DiseaseKristopher P Clark, Seyed Mehdi Nouraie, Kathleen O Lindell, et al.
Plos One|April 17, 2012
Global methylation patterns in idiopathic pulmonary fibrosisEinat I Rabinovich, Maria G Kapetanaki, Israel Steinfeld, et al.
Chest|November 2, 2013
Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trialRobert P Baughman, Daniel A Culver, Francis C Cordova, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Reply to Ronsmans et al.: Occupational and environmental exposures contribute to lung function heterogeneity in sarcoidosisSharon E Kim, Kevin F Gibson, Christopher J Ryerson, et al.
Journal of Palliative Medicine|January 8, 2019
Assessing Patterns of Palliative Care Referral and Location of Death in Patients with Idiopathic Pulmonary Fibrosis: A Sixteen-Year Single-Center Retrospective Cohort StudyRichard H Zou, Mehdi Nouraie, Xiaoping Chen, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Heart & Lung : the Journal of Critical Care|June 22, 2010
Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partnersKathleen Oare Lindell, Ellen Olshansky, Mi-Kyung Song, et al.
American Journal of Respiratory Cell and Molecular Biology|March 3, 2009
WNT5A is a regulator of fibroblast proliferation and resistance to apoptosisLouis J Vuga, Ahmi Ben-Yehudah, Elizabetha Kovkarova-Naumovski, et al.
Annals of the American Thoracic Society|May 18, 2021
Nurse-Led Palliative Care Clinical Trial Improves Knowledge and Preparedness in Caregivers of Patients with Idiopathic Pulmonary FibrosisKathleen Oare Lindell, Sara Jo Klein, Melinda S Veatch, et al.
Rheumatology (Oxford, England)|January 14, 2017
Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosisRohit Aggarwal, Christine McBurney, Frank Schneider, et al.
Annals of the American Thoracic Society|February 13, 2025
Reply to Archontakis Barakakis and Fortis: Oxygen Supplementation Goals Beyond Correcting Ambulatory Oxygen SaturationKristopher P Clark, Seyed Mehdi Nouraie, Kathleen O Lindell, et al.
Annals of the American Thoracic Society|November 20, 2024
A Ramped Treadmill Protocol Exercise Test Identifies Higher Ambulatory Oxygen Needs in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary DiseaseKristopher P Clark, Seyed Mehdi Nouraie, Kathleen O Lindell, et al.
Plos One|April 17, 2012
Global methylation patterns in idiopathic pulmonary fibrosisEinat I Rabinovich, Maria G Kapetanaki, Israel Steinfeld, et al.
Chest|November 2, 2013
Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trialRobert P Baughman, Daniel A Culver, Francis C Cordova, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Reply to Ronsmans et al.: Occupational and environmental exposures contribute to lung function heterogeneity in sarcoidosisSharon E Kim, Kevin F Gibson, Christopher J Ryerson, et al.
Journal of Palliative Medicine|January 8, 2019
Assessing Patterns of Palliative Care Referral and Location of Death in Patients with Idiopathic Pulmonary Fibrosis: A Sixteen-Year Single-Center Retrospective Cohort StudyRichard H Zou, Mehdi Nouraie, Xiaoping Chen, et al.
Pageof 8